Clomid Tablet
NDC Package 0713-0885-30
Package Information
Clomid (clomiphene citrate) tablets is a medication used to treat infertility in women. This formulation utilizes a tablet delivery system. Marketed by Cosette Pharmaceuticals, Inc., this product is identified by NDC 0713-0885 and is authorized under FDA application ANDA075528.
Identification & Billing
- RxCUI: 1093060 - clomiPHENE citrate 50 MG Oral Tablet
- RxCUI: 1093060 - clomiphene citrate 50 MG Oral Tablet
- RxCUI: 1093073 - Clomid 50 MG Oral Tablet
- RxCUI: 1093073 - clomiphene citrate 50 MG Oral Tablet [Clomid]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0713 - Cosette Pharmaceuticals, Inc.
- 0713-0885 - Clomid
- 0713-0885-30 - 3 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
- 0713-0885 - Clomid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0713-0885). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0713-0885-30 identifies a specific commercial package of 3 blister pack in 1 carton / 10 tablet in 1 blister pack of Clomid, a human prescription drug labeled by Cosette Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains clomiphene citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cosette Pharmaceuticals, Inc. on September 09, 2022. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat infertility in women. It works by stimulating an increase in the amount of hormones that support the growth and release of a mature egg (ovulation). This medication is not recommended for women whose ovaries no longer make eggs properly (primary pituitary or ovarian failure).
How is this Cosette Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00713088530. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 3 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.